Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4696214010 | Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4696215011 | Product containing dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5637101000052116 | läkemedel som innehåller dolutegravir, lamivudin och tenofovir, oral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Is a | Dolutegravir- and lamivudine- and tenofovir-containing product | true | Inferred relationship | Some | ||
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Is a | Product containing tenofovir in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Is a | Product containing dolutegravir and lamivudine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Has active ingredient | Lamivudine (substance) | true | Inferred relationship | Some | 1 | |
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Has active ingredient | Tenofovir (substance) | true | Inferred relationship | Some | 2 | |
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Has active ingredient | Dolutegravir | true | Inferred relationship | Some | 3 | |
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Is a | Lamivudine- and tenofovir-containing product in oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Dolutegravir and lamivudine and tenofovir only product in oral dose form | Is a | True | Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set